logo-loader

Accuray to acquire TomoTherapy for $277 million

Last updated: 14:41 07 Mar 2011 GMT, First published: 15:41 07 Mar 2011 GMT

no_picture_pai

Accuray (NASDAQ:ARAY), a maker of cancer therapy systems, said Monday it has agreed to acquire industry peer TomoTherapy (NASDAQ:TOMO) in a $277 million cash and stock deal.

The combined company will have more than 550 cancer therapy systems installed in 32 countries.  In 2010, the two companies had combined revenue of $416 million.  Accuray said it expects the acquisition to add to its earnings in 2012.

Under the deal, Accuray will pay $3.15 in cash and $1.65 in shares for each TomoTherapy share. The total $4.80-per-share consideration represents a 30.8% premium to TomoTherapy’s closing share price last Friday.

The deal, subject to the approval of TomoTherapy's shareholders and other closing conditions, is expected to close in the second quarter or early in the third.

Since the announcement, TomoTherapy's shares surged almost 26% to $4.62 as of 9:54 am EST.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

1 hour, 20 minutes ago